Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Focus (Am Psychiatr Publ) ; 22(1): 44-52, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38694156

ABSTRACT

Postpartum psychosis is the most severe psychiatric disorder associated with childbirth. Although rare, it is considered a psychiatric emergency that warrants immediate medical attention and inpatient care to ensure safety, complete diagnostic evaluation, and treatment initiation. This article describes the phenomenology of postpartum psychosis, clinical evaluation, treatment guidelines, and prevention strategies.

2.
Rev Bras Ortop (Sao Paulo) ; 59(1): e119-e124, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38524721

ABSTRACT

Objective: To quantify the use of social media platforms by orthopedic traumatologists with an emphasis on demographic, practice-based, and regional differences. Materials and Methods: Using the Orthopaedic Trauma Association (OTA) membership database, online searches were performed to identify professional profiles on numerous social media platforms. This presence was then quantified by a cumulative social media score which was correlated to the demographic information collected. Results: In total, 1,262 active fellowship-trained orthopedic traumatologists were identified. Surgeons practicing in an academic setting were found to be more likely to use numerous social media platforms and to present an overall greater social media score than those in private practices. No significant differences in use were found based on practice region. Conclusion: Social media platforms are currently underused by orthopedic traumatologists. Level of Evidence: IV.

3.
Cardiovasc Intervent Radiol ; 47(3): 346-353, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38409561

ABSTRACT

PURPOSE: To evaluate the Sclerograft™ procedure, which is an image-guided, minimally invasive approach of chemical sclerotherapy followed by bone grafting of unicameral bone cysts (UBC). MATERIALS AND METHODS: A retrospective evaluation from August 2018 through August 2023 was performed at a single institution on patients that underwent the Sclerograft™ procedure for UBCs. Radiographic healing was evaluated utilizing the Modified Neer Classification. Two different regenerative grafts, CaSO4-CaPO4 and HA-CaSO4 were utilized. A total of 50 patients were evaluated with 41 patients grafted with CaSO4-CaPO4 and 9 patients grafted with HA-CaSO4. RESULTS: The average age of the patient was 12.1 years with an average radiographic follow-up of 14.5 months. Average cyst size was 5.5 cm in the largest dimension and average cyst volume was 20.2 cc. 42 out of 50 (84%) showed healed cysts (Modified Neer Class 1) on the most recent radiograph or MRI. Recurrences occurred on average at 7.2 months. Activity restrictions were lifted at 3-4.5 months post-procedure. Cyst stratification by size did not show a difference in recurrence rates (p = 0.707). There was no significant difference in recurrence rate between lesions abutting the physis compared to those that were not abutting the physis (p = 0.643). There were no major complications. CONCLUSIONS: The Sclerograft™ procedure is an image-guided approach to treating unicameral bone cysts, utilizing chemical sclerosis and regenerative bone grafting. The radiographic healing of cysts compares favorably to open curettage and grafting as determined utilizing previously published trials.


Subject(s)
Bone Cysts , Humans , Child , Retrospective Studies , Bone Cysts/diagnostic imaging , Bone Cysts/surgery , Radiography , Curettage/methods , Sclerotherapy , Treatment Outcome
4.
Semin Intervent Radiol ; 40(3): 308-311, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37484447

ABSTRACT

Image-guided percutaneous biopsies are routine, safe procedures and complications are infrequent and usually directly related to the biopsy itself. This report describes a biopsy of a retroperitoneal mass with extension into the spinal canal, following which the patient developed paralysis unrelated to the biopsy itself but secondary to spinal cord ischemia during the procedure. Multiple factors contributed to the ischemia, including prone positioning, compression of spinal vasculature by the mass, low arterial pressures, and an extended duration of anesthesia. While the patient eventually recovered neurologic function, it is an important reminder to consider individual patient factors that may complicate typically routine procedures. In masses with intraspinal extension, patient positioning is critical to prevent positional ischemia, and maintaining elevated mean arterial pressures is crucial for ensuring adequate spinal perfusion throughout the procedure.

5.
J Mater Chem B ; 10(2): 224-235, 2022 01 05.
Article in English | MEDLINE | ID: mdl-34846443

ABSTRACT

To alter the immunosuppressive tumor microenvironment (TME), we developed an immunostimulatory nanoparticle (NP) to reprogram a tumor's dysfunctional and inhibitory antigen-presenting cells (APCs) into properly activated APCs that stimulate tumor-reactive cytotoxic T cells. Importantly, systemic delivery allowed NPs to efficiently utilize the entire microvasculature and gain access into the majority of the perivascular TME, which coincided with the APC-rich tumor areas leading to uptake of the NPs predominantly by APCs. In this work, a 60 nm NP was loaded with a STING agonist, which triggered robust production of interferon ß, resulting in activation of APCs. In addition to untargeted NPs, we employed 'mainstream' ligands targeting fibronectin, αvß3 integrin and P-selectin that are commonly used to direct nanoparticles to tumors. Using the 4T1 mouse model, we assessed the microdistribution of the four NP variants in the tumor immune microenvironment in three different breast cancer landscapes, including primary tumor, early metastasis, and late metastasis. The different NP variants resulted in variable uptake by immune cell subsets depending on the organ and tumor stage. Among the NP variants, therapeutic studies indicated that the untargeted NPs and the integrin-targeting NPs exhibited a remarkable short- and long-term immune response and long-lasting antitumor effect.


Subject(s)
Breast Neoplasms/therapy , Cyclic GMP/analogs & derivatives , Immunity, Innate/drug effects , Immunologic Factors/therapeutic use , Nanoparticles/chemistry , 1,2-Dipalmitoylphosphatidylcholine/chemistry , Animals , Cell Line, Tumor , Cyclic GMP/therapeutic use , Dendritic Cells/drug effects , Ligands , Macrophages/drug effects , Mice, Inbred BALB C , Peptides/chemistry , Phosphatidylcholines/chemistry , Phosphatidylethanolamines/chemistry , Polyethylene Glycols/chemistry , T-Lymphocytes/drug effects , Tumor Microenvironment/drug effects
6.
Nanoscale Horiz ; 6(2): 156-167, 2021 02 01.
Article in English | MEDLINE | ID: mdl-33400743

ABSTRACT

The high mortality associated with glioblastoma multiforme (GBM) is attributed to its invasive nature, hypoxic core, resistant cell subpopulations and a highly immunosuppressive tumor microenvironment (TME). To support adaptive immune function and establish a more robust antitumor immune response, we boosted the local innate immune compartment of GBM using an immunostimulatory mesoporous silica nanoparticle, termed immuno-MSN. The immuno-MSN was specifically designed for systemic and proficient delivery of a potent innate immune agonist to dysfunctional antigen-presenting cells (APCs) in the brain TME. The cargo of the immuno-MSN was cyclic diguanylate monophosphate (cdGMP), a Stimulator of Interferon Gene (STING) agonist. Studies showed the immuno-MSN promoted the uptake of STING agonist by APCs in vitro and the subsequent release of the pro-inflammatory cytokine interferon ß, 6-fold greater than free agonist. In an orthotopic GBM mouse model, systemically administered immuno-MSN particles were taken up by APCs in the near-perivascular regions of the brain tumor with striking efficiency. The immuno-MSNs facilitated the recruitment of dendritic cells and macrophages to the TME while sparing healthy brain tissue and peripheral organs, resulting in elevated circulating CD8+ T cell activity (2.5-fold) and delayed GBM tumor growth. We show that an engineered immunostimulatory nanoparticle can support pro-inflammatory innate immune function in GBM and subsequently augment current immunotherapeutic interventions and improve their therapeutic outcome.


Subject(s)
Brain Neoplasms/therapy , Cyclic GMP/analogs & derivatives , Glioblastoma/therapy , Immunity, Innate/drug effects , Immunologic Factors/therapeutic use , Nanoparticles/therapeutic use , Animals , Antigen-Presenting Cells/drug effects , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/therapeutic use , CD8-Positive T-Lymphocytes/drug effects , Cyclic GMP/chemical synthesis , Cyclic GMP/therapeutic use , Dendritic Cells/drug effects , Female , Immunologic Factors/chemical synthesis , Immunotherapy/methods , Interferon Type I/metabolism , Macrophages/drug effects , Mice , Mice, Inbred C57BL , Porosity , RAW 264.7 Cells , Silicon Dioxide/chemistry , Tumor Microenvironment/drug effects
7.
Cancer Res ; 79(20): 5394-5406, 2019 10 15.
Article in English | MEDLINE | ID: mdl-31431457

ABSTRACT

Effective cancer immunotherapy depends on the robust activation of tumor-specific antigen-presenting cells (APC). Immune agonists encapsulated within nanoparticles (NP) can be delivered to tumor sites to generate powerful antitumor immune responses with minimal off-target dissemination. Systemic delivery enables widespread access to the microvasculature and draining to the APC-rich perivasculature. We developed an immuno-nanoparticle (immuno-NP) coloaded with cyclic diguanylate monophosphate, an agonist of the stimulator of interferon genes pathway, and monophosphoryl lipid A, and a Toll-like receptor 4 agonist, which synergize to produce high levels of type I IFNß. Using a murine model of metastatic triple-negative breast cancer, systemic delivery of these immuno-NPs resulted in significant therapeutic outcomes due to extensive upregulation of APCs and natural killer cells in the blood and tumor compared with control treatments. These results indicate that NPs can facilitate systemic delivery of multiple immune-potentiating cargoes for effective APC-driven local and systemic antitumor immunity. SIGNIFICANCE: Systemic administration of an immuno-nanoparticle in a murine breast tumor model drives a robust tumor site-specific APC response by delivering two synergistic immune-potentiating molecules, highlighting the potential of nanoparticles for immunotherapy.


Subject(s)
Antigen-Presenting Cells/immunology , Cyclic GMP/analogs & derivatives , Drug Delivery Systems/methods , Interferon-beta/physiology , Lipid A/analogs & derivatives , Mammary Neoplasms, Experimental/drug therapy , Melanoma, Experimental/drug therapy , Nanocapsules/administration & dosage , Toll-Like Receptor 4/agonists , Triple Negative Breast Neoplasms/drug therapy , Animals , Antigen-Presenting Cells/drug effects , Cyclic GMP/administration & dosage , Cyclic GMP/therapeutic use , Drug Screening Assays, Antitumor , Drug Synergism , Female , Killer Cells, Natural/immunology , Lipid A/administration & dosage , Lipid A/therapeutic use , Lymphocytes, Tumor-Infiltrating/immunology , Mammary Neoplasms, Experimental/immunology , Mammary Neoplasms, Experimental/pathology , Melanoma, Experimental/immunology , Melanoma, Experimental/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Microcirculation , Triple Negative Breast Neoplasms/immunology , Triple Negative Breast Neoplasms/pathology
8.
Bioelectromagnetics ; 37(7): 433-43, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27553635

ABSTRACT

There is still uncertainty whether extremely low frequency electromagnetic fields (ELF-EMF) can induce health effects like immunomodulation. Despite evidence obtained in vitro, an unambiguous association has not yet been established in vivo. Here, mice were exposed to ELF-EMF for 1, 4, and 24 h/day in a short-term (1 week) and long-term (15 weeks) set-up to investigate whole body effects on the level of stress regulation and immune response. ELF-EMF signal contained multiple frequencies (20-5000 Hz) and a magnetic flux density of 10 µT. After exposure, blood was analyzed for leukocyte numbers (short-term and long-term) and adrenocorticotropic hormone concentration (short-term only). Furthermore, in the short-term experiment, stress-related parameters, corticotropin-releasing hormone, proopiomelanocortin (POMC) and CYP11A1 gene-expression, respectively, were determined in the hypothalamic paraventricular nucleus, pituitary, and adrenal glands. In the short-term but not long-term experiment, leukocyte counts were significantly higher in the 24 h-exposed group compared with controls, mainly represented by increased neutrophils and CD4 ± lymphocytes. POMC expression and plasma adrenocorticotropic hormone were significantly lower compared with unexposed control mice. In conclusion, short-term ELF-EMF exposure may affect hypothalamic-pituitary-adrenal axis activation in mice. Changes in stress hormone release may explain changes in circulating leukocyte numbers and composition. Bioelectromagnetics. 37:433-443, 2016. © 2016 The Authors. Bioelectromagnetics Published by Wiley Periodicals, Inc.


Subject(s)
Electromagnetic Fields/adverse effects , Hypothalamo-Hypophyseal System/cytology , Hypothalamo-Hypophyseal System/radiation effects , Leukocyte Count , Pituitary-Adrenal System/cytology , Pituitary-Adrenal System/radiation effects , Signal Transduction/radiation effects , Animals , Mice , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...